Hubei Minkang Pharmaceutical Ltd

Company Snapshot
No. 50 Xiba Road
Yichang,
China
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees:
Please select from the dropdown
Company Financials

2011
2012
2013
Gross Profit
$0
$6,755,706
$6,289,395
Operating Income
-$67,132
$1,024,314
$41,953
Net Income
-$768,816
$961,120
$127,268
2011
Gross Profit
$0
Operating Income
-$67,132
Net Income
-$768,816
2012
Gross Profit
$6,755,706
Operating Income
$1,024,314
Net Income
$961,120
2013
Gross Profit
$6,289,395
Operating Income
$41,953
Net Income
$127,268
The above data on Hubei Minkang Pharmaceutical Ltd came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Director, Chief Executive Officer, Chief Financial Officer and President
$300,636
$0
$162,000
$462,636
$462,636
Director, Chief Executive Officer, Chief Financial Officer and President
Secretary, Treasurer and Director
$222,636
$0
$120,000
$342,636
$342,636
Secretary, Treasurer and Director
Hubei Minkang Pharmaceutical Ltd listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2013. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us